Company Creation | Business and Partnerships | Newcastle University
Source: https://www.ncl.ac.uk/business-and-partnerships/expert-solutions/company-creation
Archived: 2026-04-23 17:18
Company Creation | Business and Partnerships | Newcastle University
ðŸ?
Skip to main content
Business and Partnerships
Careers
Library
Current Students
Staff
News & Press
Events
Contact
Logo
Business and Partnerships
Expert Solutions
Expert Solutions
Arrow
Clinical Trials & Research
Continuing Professional Development
Collaborative Research
Dyson
Company Creation
Consultancy
Corporate Partnerships
National Trust
Driving the Electric Revolution Industrial Centres
Higher and Degree Apprenticeships
DA L6 BEng Product Design and Dev Engineer
Facilities and Equipment
Knowledge Transfer Partnerships
Learning Partnerships
Learning Partnerships Events
Technology Transfer and Licensing
Sector overviews
Offshore wind
Space
Clean technology
Investment Prospectus
Investment Prospectus
Ageing and Longevity
Investing in Innovation
Driving a Cleaner Greener Future
People
Case Studies
Latest News
Blog
Contact Us
Newcastle University
Business and Partnerships
Expert Solutions
Company Creation
On this page
Our Company Creation
We support and facilitate the creation of high-tech, innovative companies. We identify and "spin out" commercial and not-for-profit activities from our world class research.
You might be interested in investing or partnering with one of our companies. Or you might want to join as an experienced executive who can support a company's growth.
If you're an investor, an adviser or an academic and interested in working with us and our portfolio of companies,
please get in touch
.
Spin out companies
We have an excellent track record for producing spin-out companies from applied research. We also play a significant role in the development of new products and services.
Our spin out companies contribute to the development and vitality of the region through new jobs and revenue creation.
Executives into business
We support our deep tech and innovative spin-out companies to maximize their growth and success. This may involve recruiting executives with a high level of business acumen and experience in scaling up businesses.
We want to attract ambitious, experienced, and well-networked business executives to early-stage ventures. We offer remuneration and equity. We are particularly looking for executives with experience in deep tech life sciences and engineering. If you believe you have the skills and experience to lead a spin-out business, or want to find out more, get in touch.
Northern Accelerator
We are founding members of the Northern Accelerator programme. This is a collaboration between the universities in the north east of England. The programme has accelerated the commercialisation of innovation. It boosts our region’s economy, making a real-world impact from world-leading research.
Find out more about Northern Accelerator
Information for investors
Our spin-out companies are at the forefront of innovation, transforming groundbreaking ideas and discoveries into commercial, high growth propositions.
Whether angel, venture or institutional investing, we can present:
Early access to high-growth venture
: engage with promising companies at the forefront of innovation.
Robust due diligence and support:
our experienced teams ensure transparency and strategic alignment of your aims and our spin-outs.
Ongoing collaboration opportunities:
build long-term partnerships with the University and its vibrant entrepreneurial network including our angel group.
Our
intellectual property policy
is a public document. It outlines the support we offer to spin-out company creation and our founding equity position.
Investing in Newcastle University spin-outs is more than a financial opportunity. It’s a chance to be part of a transformative journey. Together, we can accelerate innovation, deliver impact, and create lasting value.
List of our current spin-outs
Advanced Electric Machines
The unique, low cost traction motor technology will drive tomorrow's hybrid, range extended and electric commercial vehicles. The technology delivers excellent performance in a robust package.
Find out more about Advanced Electric Machines
Aelius Biotech
Aelius Biotech is a contract research company specialising in modelling the mucosal surfaces of the aerodigestive tract. Aelius' Integrated Model Gut System is a lab model. It stretches from the mouth to the large intestine. It can be used to test drug delivery and absorption, screen formulations, develop and test functional foods and study pre- and pro- biotics.
Find out more about Aelius Biotech
Alcyomics
Alcyomics is a UK based unique pre-clinical service provider using Skimune®. This is a non-artificial human skin explant for safety and efficacy assessment of novel compounds and drugs. Their aim is to provide novel solutions for pre-clinical drug safety and efficacy testing for therapeutics. This includes cellular therapies and to extend its technologies for use in the chemical and cosmetic industries.
Find out more about Alcyomics
Armatus Oceanic
Armatus Oceanic is deep-sea venture focused on making the deep sea accessible to all. They continue to develop and deploy underwater technology. This allows the exploration and surveying of up to 11,000 meters below the ocean’s surface.
Find out more about Armatus Oceanics
Atelerix
Atelerix offers a transformative hydrogel technology for the storage and transport of viable cells. This includes stem cells and cell-based assays at ambient temperatures. It overcomes the barriers presented by the current need for cryo-shipping. It's simple, cell-friendly and offers immediate access to stem cell therapies.
Find out more about Atelerix
APIX Nutrition
Apix Nutrition's proprietary range of novel feeds for honeybees delivers a balanced and healthy diet in pre-pack and ready-to-eat formats. Their aim is to address a failure in the market for effective bee nutrition throughout the world.
Find out more about APIX Nutrition
3D Bio-Tissues
3D Bio-Tissues is a leading provider of cutting-edge technologies in corneal 3D printing. Professor Che Connon at Newcastle University founded the company.
20 years of knowledge, performing cutting edge research, was fundamental to the understanding of how the cornea works
.
Find out more about 3D Bio-Tissues
Demuris (Odyssey)
Demuris is a drug discovery and development company. It employs state-of-the-art platform technologies in natural product discovery, design and production. Demuris’ portfolio of new drug development often lies in a unique collection of Actinomycete bacteria. They can manipulate the behaviour of surrounding organisms, including bacteria, fungi, plants and animals.
Find out more about Demuris (Odyssey)
Dragonfly Insulation
Dragonfly Insulation Ltd scales up aerogel manufacture.
Based on innovative and simplified manufacturing processes, with low energy consumption, it offers various forms of aerogel products
.
Find out more about Dragonfly Insulation
ESP Diagnostics (ESPDx)
ESPDx developed a simple and accurate test for early-stage diagnosis and early pre-symptomatic detection of both dementia with Lewy Bodies and Parkinson's disease. The test measures biomarkers in extracellular vesicles. It enables early and accurate diagnosis of neurodegenerative disorders for:
patients
clinicians
healthcare providers
drug developers
Find out more about ESP Diagnostics
FibroFind
FibroFind provides world class research solutions in liver, kidney and lung disease.
In 2025, FibroFind was acquired by private equity firm Vespa Capital.
Find out more about FibroFind
GitLife
GitLife have introduced CellRepo, the first Version Control System for Synthetic Biology. They aim to set the global standard in the management of provenance and integrity for biological assets; enabling the potential of synthetic biology to be realised worldwide.
Find out more about GitLife
GlycoScore
GlycoScore is a patented blood test that detects a panel of novel biomarkers and can accurately diagnose prostate cancer. The GlycoScore analytes are detected using a simple method called ELISA. This makes the test easily adoptable by pathology labs worldwide with no additional capital investment needed.
Find out more about GlycoScore
Gnosis Health
Gnosis Health is an AI-driven SaaS company transforming chronic disease management, starting with Parkinson’s disease. Their propriety AI digital assistant, MAXine, provides an integrated digital health platform that enhances patient self-management, improves clinical decision-making, and alleviates pressure on overstretched healthcare systems.
Find out more about Gnosis Health
Indicatrix Crystallography
Indicatrix offers a unique under oil micro crystallisation technique for the crystallisation of organic soluble small molecules. This enables solid state molecular structural analysis in the pharmaceutical and chemical industries. Indicatrix performs thousands of individual experiments with only a few milligrams of analyte. It enables them to solve the most challenging industrial small molecule crystallisation problems.
Find out more about Indicatrix Crystallography
JawSpace
JawSpace is a company that ‘spun in’ to the University in 2024. JawSpace provides guidance and the opportunity for people to self-manage Temporomandibular Disorders (TMD). TMD are a group of conditions affecting the jaw joint and associated structures including the muscles that move it. TMD are the 2nd most common cause of facial pain after toothache and can also result in difficulties with jaw function, e.g. limited mouth opening or ‘locking’.
JawSpace provides comprehensive self-management tools and strategies tailored to the individual user, helping them to live well by effectively managing their TMD symptoms.
Find out more at:
www.jawspace.com
JetBio
Jetbio has been established to commercialise Newcastle University's patented bioprinting technology. Their reactive jet impingement (ReJI) bioprinting technology is a fast, flexible system for printing biomimetic cell filled gels for use in developing in vitro disease models for drug testing, or to support regenerative medicine.
Find out more about JetBio
Latest news:
Spin-out unveils world-leading technology to speed up drug discovery
Literal Labs
Literal Labs aims to redefine Artificial Intelligence and make AI a universally accessible tool. Their focus is developing a novel edge, AI chip architecture that is based on propositional logic.
Find out more about Literal Labs
Marrabio
MarraBio design, engineer and construct bacterial protein polymers, that contain the biological messages that cells need to grow, divide, and behave properly. Cells grown on an industrial scale for research, agricultural or therapeutic use need to be supplied with the right signals. MarraBio provide a multi-functional, cost-effective solution in a single, easy to use material.
Find out more about MarraBio
METzero
METzero helps water companies decarbonise and get value out of their wastewater.
The company's technology uses
Microbial Electrolysis Cells (MECs) to treat wastewater in an innovative way
.
Naturally occurring electrogenic bacteria digest organic waste anaerobically. These bacteria donate electrons to an electrical circuit during this process, producing a small current.
To enhance the efficiency and output of our system, we apply a controlled potential difference across the electrodes. This adjustment allows us to generate various valuable by-products at the cathode, such as hydrogen and ammonia, directly from the treatment process.
Find out more on the METzero website
.
Microbritt
Microbritt is a rapid micro-manufacturing company. It's similar to 3D printing services for the manufacturing of novel complex microscale products from brittle materials, like silicon. Customers are able to make products which can't be manufactured using conventional technology. They also make them faster.
Listen to the podcast
Website
Find out more about Microbritt
Newcells Biotech
Newcells Biotech specialises in producing induced pluripotent stem cells and their differentiation into various cell and tissue types. They offer high quality cells and services for customers engaged in:
drug discovery
pre-clinical development
disease mechanism investigation
Find out more about Newcells Biotech
NunaBio
NunaBio invents, designs and engineers new technologies and products for chemical and biological applications. Their main areas of focus include:
biosensing in various industries
DNA/gene production for cell and gene therapies
vaccines
diagnostics
Find out more about NunaBio
Ocular Systems
OCULAR is developing a novel non-destructive 3D particle characterisation tool that will predict the functional behaviour of particulate systems at scale-up and manufacturing steps from g-scale samples. OCULAR is the first particle shape characterisation instrument of its kind, performing characterisation using a 3D reconstruction of a particle to generate a precise knowledge of particle morphology.
Find more about Ocular Systems.
Recovolt
RecoVolt is an equipment, software and services provider that facilitates key elements of the circular economy, critical to lithium-ion battery recycling. Enabling battery ‘second life’ reuse to support electric vehicle residual value and accelerate take-up. RecoVolt is positioned to become a critical infrastructure provider in EV battery management, enabling third-party stakeholders to manage batteries more effectively.
Find out more about Recovolt.
Sapien View
Sapien View is an exciting spin out opportunity led by Professor Colin Wilson, transplant surgeon and Honorary Professor at Newcastle University. The first product to be launched is an Organ Quality Assessment tool (“OrQA”) which uses visual AI to aid surgeons when assessing organs for transplantation. This will create the first global objective standard score for assessing the viability of an organ for transplant which in turn is expected to lead to a global increase in transplantations of Livers (OrQA-L), Kidneys (OrQA-K) and Pancreas (OrQA-P). This will save lives, increase revenues for transplant centres and reduce dialysis costs.
ScubaTx
ScubaTx develops technology to preserve organs. In doing so they offer healthcare providers significant net savings. They help clinicians around the world to increase the pool of life-giving organs.
Find out more about ScubaTx
Skin Life Analytics
Skin Life Analytics developed a non-invasive test that can reveal if a person's skin is at risk of ageing prematurely. This could be from lifestyle risks such as exposure to sunlight and poor sleep, which can damage skin cells. In addition to a skin swab, the test includes a lifestyle assessment that can suggest changes to improve skin condition. They also utilise face scan technology to pinpoint areas that would benefit from a targeted care regime.
Find out more about Skin Life Analytics
Smartcoater
Smartcoater have developed a revolutionary Layer-by-Layer (LbL) coating platform which has transformative performance, cost and speed advantage in the coating market. By creating a hybrid of atomised spray and dip technologies in a patent-protected method that maximises the benefits while eliminating the drawbacks, Smartcoater are well-positioned to solve a number of pressing performance and regulatory issues in the functional coating market and disrupt the industry.
Tangram Therapeutics
Formerly known as e-Therapeutics,
Tangram Therapeutics
accelerates drug discovery through a novel view of disease networks. They combine a computer-based platform and biological expertise to create and analyse disease network models. Potential proteins are identified that could be disrupted to treat the disease.
Find out more about Tangram Therapeutics
TREAT-NMD
TREAT-NMD is a network for the neuromuscular field. It provides an infrastructure to ensure that the most promising new therapies reach patients as quickly as possible. Their focus is to develop tools that industry, clinicians and scientists need to bring novel therapeutic approaches through preclinical development and into the clinic.
Find out more about TREAT-NMD
XR Therapeutics
XR Therapeutics (XRT) provides a step-change in the way therapeutic interventions for anxiety are delivered. This is for people with autism, phobias and situation-specific anxieties. XRT's product integrates traditional CBT and exposure therapies using various virtual reality environments.
Listen to the podcast
Website
Find out more about XR Therapeutics
Our Team
We have extensive, hands on experience of creating and successfully managing new businesses. Our team includes:
Rick McCordall
, Head of Company Creation
Andrew Hodgson, Company Creation Manager
James Tetley
, Company Creation Commercial Advisor
Caitlin Jardine
, Company Creation Administrator
If you would like to discuss any business opportunities with the team please contact
Caitlin Jardine
, our Company Creation Administrator.
Latest Company Creation News
NunaBio wins Accelerating Innovation Award at CPHI Frankfurt
Newcastle University spin-out NunaBio has been awarded the prestigious Accelerating Innovation Award at CPHI Frankfurt, recognising its pioneering work in synthetic DNA manufacturing.
Literal Labs raises £4.6M in pre-seed round
The spin-out's Tsetlin machine approach is developing faster machine learning that uses less energy. The investment is also Northern Gritstone’s first investment linked to Newcastle University.
FibroFind acquired to drive global growth in drug development
The Newcastle University spin-out has been acquired by private equity firm Vespa Capital in a move set to accelerate the company’s international growth.
Sign up to receive our newsletter
Get the latest business news and events.
Sign up for our newsletter
ðŸ?
Skip to main content
Business and Partnerships
Careers
Library
Current Students
Staff
News & Press
Events
Contact
Logo
Business and Partnerships
Expert Solutions
Expert Solutions
Arrow
Clinical Trials & Research
Continuing Professional Development
Collaborative Research
Dyson
Company Creation
Consultancy
Corporate Partnerships
National Trust
Driving the Electric Revolution Industrial Centres
Higher and Degree Apprenticeships
DA L6 BEng Product Design and Dev Engineer
Facilities and Equipment
Knowledge Transfer Partnerships
Learning Partnerships
Learning Partnerships Events
Technology Transfer and Licensing
Sector overviews
Offshore wind
Space
Clean technology
Investment Prospectus
Investment Prospectus
Ageing and Longevity
Investing in Innovation
Driving a Cleaner Greener Future
People
Case Studies
Latest News
Blog
Contact Us
Newcastle University
Business and Partnerships
Expert Solutions
Company Creation
On this page
Our Company Creation
We support and facilitate the creation of high-tech, innovative companies. We identify and "spin out" commercial and not-for-profit activities from our world class research.
You might be interested in investing or partnering with one of our companies. Or you might want to join as an experienced executive who can support a company's growth.
If you're an investor, an adviser or an academic and interested in working with us and our portfolio of companies,
please get in touch
.
Spin out companies
We have an excellent track record for producing spin-out companies from applied research. We also play a significant role in the development of new products and services.
Our spin out companies contribute to the development and vitality of the region through new jobs and revenue creation.
Executives into business
We support our deep tech and innovative spin-out companies to maximize their growth and success. This may involve recruiting executives with a high level of business acumen and experience in scaling up businesses.
We want to attract ambitious, experienced, and well-networked business executives to early-stage ventures. We offer remuneration and equity. We are particularly looking for executives with experience in deep tech life sciences and engineering. If you believe you have the skills and experience to lead a spin-out business, or want to find out more, get in touch.
Northern Accelerator
We are founding members of the Northern Accelerator programme. This is a collaboration between the universities in the north east of England. The programme has accelerated the commercialisation of innovation. It boosts our region’s economy, making a real-world impact from world-leading research.
Find out more about Northern Accelerator
Information for investors
Our spin-out companies are at the forefront of innovation, transforming groundbreaking ideas and discoveries into commercial, high growth propositions.
Whether angel, venture or institutional investing, we can present:
Early access to high-growth venture
: engage with promising companies at the forefront of innovation.
Robust due diligence and support:
our experienced teams ensure transparency and strategic alignment of your aims and our spin-outs.
Ongoing collaboration opportunities:
build long-term partnerships with the University and its vibrant entrepreneurial network including our angel group.
Our
intellectual property policy
is a public document. It outlines the support we offer to spin-out company creation and our founding equity position.
Investing in Newcastle University spin-outs is more than a financial opportunity. It’s a chance to be part of a transformative journey. Together, we can accelerate innovation, deliver impact, and create lasting value.
List of our current spin-outs
Advanced Electric Machines
The unique, low cost traction motor technology will drive tomorrow's hybrid, range extended and electric commercial vehicles. The technology delivers excellent performance in a robust package.
Find out more about Advanced Electric Machines
Aelius Biotech
Aelius Biotech is a contract research company specialising in modelling the mucosal surfaces of the aerodigestive tract. Aelius' Integrated Model Gut System is a lab model. It stretches from the mouth to the large intestine. It can be used to test drug delivery and absorption, screen formulations, develop and test functional foods and study pre- and pro- biotics.
Find out more about Aelius Biotech
Alcyomics
Alcyomics is a UK based unique pre-clinical service provider using Skimune®. This is a non-artificial human skin explant for safety and efficacy assessment of novel compounds and drugs. Their aim is to provide novel solutions for pre-clinical drug safety and efficacy testing for therapeutics. This includes cellular therapies and to extend its technologies for use in the chemical and cosmetic industries.
Find out more about Alcyomics
Armatus Oceanic
Armatus Oceanic is deep-sea venture focused on making the deep sea accessible to all. They continue to develop and deploy underwater technology. This allows the exploration and surveying of up to 11,000 meters below the ocean’s surface.
Find out more about Armatus Oceanics
Atelerix
Atelerix offers a transformative hydrogel technology for the storage and transport of viable cells. This includes stem cells and cell-based assays at ambient temperatures. It overcomes the barriers presented by the current need for cryo-shipping. It's simple, cell-friendly and offers immediate access to stem cell therapies.
Find out more about Atelerix
APIX Nutrition
Apix Nutrition's proprietary range of novel feeds for honeybees delivers a balanced and healthy diet in pre-pack and ready-to-eat formats. Their aim is to address a failure in the market for effective bee nutrition throughout the world.
Find out more about APIX Nutrition
3D Bio-Tissues
3D Bio-Tissues is a leading provider of cutting-edge technologies in corneal 3D printing. Professor Che Connon at Newcastle University founded the company.
20 years of knowledge, performing cutting edge research, was fundamental to the understanding of how the cornea works
.
Find out more about 3D Bio-Tissues
Demuris (Odyssey)
Demuris is a drug discovery and development company. It employs state-of-the-art platform technologies in natural product discovery, design and production. Demuris’ portfolio of new drug development often lies in a unique collection of Actinomycete bacteria. They can manipulate the behaviour of surrounding organisms, including bacteria, fungi, plants and animals.
Find out more about Demuris (Odyssey)
Dragonfly Insulation
Dragonfly Insulation Ltd scales up aerogel manufacture.
Based on innovative and simplified manufacturing processes, with low energy consumption, it offers various forms of aerogel products
.
Find out more about Dragonfly Insulation
ESP Diagnostics (ESPDx)
ESPDx developed a simple and accurate test for early-stage diagnosis and early pre-symptomatic detection of both dementia with Lewy Bodies and Parkinson's disease. The test measures biomarkers in extracellular vesicles. It enables early and accurate diagnosis of neurodegenerative disorders for:
patients
clinicians
healthcare providers
drug developers
Find out more about ESP Diagnostics
FibroFind
FibroFind provides world class research solutions in liver, kidney and lung disease.
In 2025, FibroFind was acquired by private equity firm Vespa Capital.
Find out more about FibroFind
GitLife
GitLife have introduced CellRepo, the first Version Control System for Synthetic Biology. They aim to set the global standard in the management of provenance and integrity for biological assets; enabling the potential of synthetic biology to be realised worldwide.
Find out more about GitLife
GlycoScore
GlycoScore is a patented blood test that detects a panel of novel biomarkers and can accurately diagnose prostate cancer. The GlycoScore analytes are detected using a simple method called ELISA. This makes the test easily adoptable by pathology labs worldwide with no additional capital investment needed.
Find out more about GlycoScore
Gnosis Health
Gnosis Health is an AI-driven SaaS company transforming chronic disease management, starting with Parkinson’s disease. Their propriety AI digital assistant, MAXine, provides an integrated digital health platform that enhances patient self-management, improves clinical decision-making, and alleviates pressure on overstretched healthcare systems.
Find out more about Gnosis Health
Indicatrix Crystallography
Indicatrix offers a unique under oil micro crystallisation technique for the crystallisation of organic soluble small molecules. This enables solid state molecular structural analysis in the pharmaceutical and chemical industries. Indicatrix performs thousands of individual experiments with only a few milligrams of analyte. It enables them to solve the most challenging industrial small molecule crystallisation problems.
Find out more about Indicatrix Crystallography
JawSpace
JawSpace is a company that ‘spun in’ to the University in 2024. JawSpace provides guidance and the opportunity for people to self-manage Temporomandibular Disorders (TMD). TMD are a group of conditions affecting the jaw joint and associated structures including the muscles that move it. TMD are the 2nd most common cause of facial pain after toothache and can also result in difficulties with jaw function, e.g. limited mouth opening or ‘locking’.
JawSpace provides comprehensive self-management tools and strategies tailored to the individual user, helping them to live well by effectively managing their TMD symptoms.
Find out more at:
www.jawspace.com
JetBio
Jetbio has been established to commercialise Newcastle University's patented bioprinting technology. Their reactive jet impingement (ReJI) bioprinting technology is a fast, flexible system for printing biomimetic cell filled gels for use in developing in vitro disease models for drug testing, or to support regenerative medicine.
Find out more about JetBio
Latest news:
Spin-out unveils world-leading technology to speed up drug discovery
Literal Labs
Literal Labs aims to redefine Artificial Intelligence and make AI a universally accessible tool. Their focus is developing a novel edge, AI chip architecture that is based on propositional logic.
Find out more about Literal Labs
Marrabio
MarraBio design, engineer and construct bacterial protein polymers, that contain the biological messages that cells need to grow, divide, and behave properly. Cells grown on an industrial scale for research, agricultural or therapeutic use need to be supplied with the right signals. MarraBio provide a multi-functional, cost-effective solution in a single, easy to use material.
Find out more about MarraBio
METzero
METzero helps water companies decarbonise and get value out of their wastewater.
The company's technology uses
Microbial Electrolysis Cells (MECs) to treat wastewater in an innovative way
.
Naturally occurring electrogenic bacteria digest organic waste anaerobically. These bacteria donate electrons to an electrical circuit during this process, producing a small current.
To enhance the efficiency and output of our system, we apply a controlled potential difference across the electrodes. This adjustment allows us to generate various valuable by-products at the cathode, such as hydrogen and ammonia, directly from the treatment process.
Find out more on the METzero website
.
Microbritt
Microbritt is a rapid micro-manufacturing company. It's similar to 3D printing services for the manufacturing of novel complex microscale products from brittle materials, like silicon. Customers are able to make products which can't be manufactured using conventional technology. They also make them faster.
Listen to the podcast
Website
Find out more about Microbritt
Newcells Biotech
Newcells Biotech specialises in producing induced pluripotent stem cells and their differentiation into various cell and tissue types. They offer high quality cells and services for customers engaged in:
drug discovery
pre-clinical development
disease mechanism investigation
Find out more about Newcells Biotech
NunaBio
NunaBio invents, designs and engineers new technologies and products for chemical and biological applications. Their main areas of focus include:
biosensing in various industries
DNA/gene production for cell and gene therapies
vaccines
diagnostics
Find out more about NunaBio
Ocular Systems
OCULAR is developing a novel non-destructive 3D particle characterisation tool that will predict the functional behaviour of particulate systems at scale-up and manufacturing steps from g-scale samples. OCULAR is the first particle shape characterisation instrument of its kind, performing characterisation using a 3D reconstruction of a particle to generate a precise knowledge of particle morphology.
Find more about Ocular Systems.
Recovolt
RecoVolt is an equipment, software and services provider that facilitates key elements of the circular economy, critical to lithium-ion battery recycling. Enabling battery ‘second life’ reuse to support electric vehicle residual value and accelerate take-up. RecoVolt is positioned to become a critical infrastructure provider in EV battery management, enabling third-party stakeholders to manage batteries more effectively.
Find out more about Recovolt.
Sapien View
Sapien View is an exciting spin out opportunity led by Professor Colin Wilson, transplant surgeon and Honorary Professor at Newcastle University. The first product to be launched is an Organ Quality Assessment tool (“OrQA”) which uses visual AI to aid surgeons when assessing organs for transplantation. This will create the first global objective standard score for assessing the viability of an organ for transplant which in turn is expected to lead to a global increase in transplantations of Livers (OrQA-L), Kidneys (OrQA-K) and Pancreas (OrQA-P). This will save lives, increase revenues for transplant centres and reduce dialysis costs.
ScubaTx
ScubaTx develops technology to preserve organs. In doing so they offer healthcare providers significant net savings. They help clinicians around the world to increase the pool of life-giving organs.
Find out more about ScubaTx
Skin Life Analytics
Skin Life Analytics developed a non-invasive test that can reveal if a person's skin is at risk of ageing prematurely. This could be from lifestyle risks such as exposure to sunlight and poor sleep, which can damage skin cells. In addition to a skin swab, the test includes a lifestyle assessment that can suggest changes to improve skin condition. They also utilise face scan technology to pinpoint areas that would benefit from a targeted care regime.
Find out more about Skin Life Analytics
Smartcoater
Smartcoater have developed a revolutionary Layer-by-Layer (LbL) coating platform which has transformative performance, cost and speed advantage in the coating market. By creating a hybrid of atomised spray and dip technologies in a patent-protected method that maximises the benefits while eliminating the drawbacks, Smartcoater are well-positioned to solve a number of pressing performance and regulatory issues in the functional coating market and disrupt the industry.
Tangram Therapeutics
Formerly known as e-Therapeutics,
Tangram Therapeutics
accelerates drug discovery through a novel view of disease networks. They combine a computer-based platform and biological expertise to create and analyse disease network models. Potential proteins are identified that could be disrupted to treat the disease.
Find out more about Tangram Therapeutics
TREAT-NMD
TREAT-NMD is a network for the neuromuscular field. It provides an infrastructure to ensure that the most promising new therapies reach patients as quickly as possible. Their focus is to develop tools that industry, clinicians and scientists need to bring novel therapeutic approaches through preclinical development and into the clinic.
Find out more about TREAT-NMD
XR Therapeutics
XR Therapeutics (XRT) provides a step-change in the way therapeutic interventions for anxiety are delivered. This is for people with autism, phobias and situation-specific anxieties. XRT's product integrates traditional CBT and exposure therapies using various virtual reality environments.
Listen to the podcast
Website
Find out more about XR Therapeutics
Our Team
We have extensive, hands on experience of creating and successfully managing new businesses. Our team includes:
Rick McCordall
, Head of Company Creation
Andrew Hodgson, Company Creation Manager
James Tetley
, Company Creation Commercial Advisor
Caitlin Jardine
, Company Creation Administrator
If you would like to discuss any business opportunities with the team please contact
Caitlin Jardine
, our Company Creation Administrator.
Latest Company Creation News
NunaBio wins Accelerating Innovation Award at CPHI Frankfurt
Newcastle University spin-out NunaBio has been awarded the prestigious Accelerating Innovation Award at CPHI Frankfurt, recognising its pioneering work in synthetic DNA manufacturing.
Literal Labs raises £4.6M in pre-seed round
The spin-out's Tsetlin machine approach is developing faster machine learning that uses less energy. The investment is also Northern Gritstone’s first investment linked to Newcastle University.
FibroFind acquired to drive global growth in drug development
The Newcastle University spin-out has been acquired by private equity firm Vespa Capital in a move set to accelerate the company’s international growth.
Sign up to receive our newsletter
Get the latest business news and events.
Sign up for our newsletter